Oral Contraceptives May Benefit Women With Asthma
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Oral Contraceptives May Benefit Women With Asthma

NORTHBROOK, Ill -- November 6, 2009 -- New research shows that during natural menstrual cycles, women with asthma who were not taking oral contraceptives (OC) had lower exhaled nitric oxide levels (eNO), a marker of airway inflammation associated with asthma, than women who were taking OC.

Furthermore, among women not using oral contraceptives, an increase in oestrogen levels was associated with a decrease in eNO, while an increase in progesterone was significantly associated with an increase in eNO.

Researchers speculate that OC may have a potential role in the management of premenopausal women with asthma.

For the study, researchers from McMaster University, Hamilton, Ontario, studied 17 women with asthma during their menstrual cycles. Of 534 potential daily visits, 526 (98.5%) were completed.

Women not using OC (n = 8) had higher mean eNO levels than women using OC (P <= .005).

In contrast, an increase in progesterone level of 0.5 nmol/L was significantly associated with an increase in eNO (P <= .05).

There were no significant associations between sex hormones and markers of asthma among women using OC.

Significant changes in asthma and atopy occur throughout the menstrual cycle, the authors wrote. Characteristics of asthma vary throughout the menstrual cycle in relation to changes in the levels of oestrogen or progesterone and this variation is attenuated in women using OC.

SOURCE: American College of Chest Physicians

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities